HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Serum and synovial fluid levels of tumor necrosis factor-like ligand 1A and decoy receptor 3 in rheumatoid arthritis.

AbstractOBJECTIVE:
To measure the levels of Tumor necrosis factor (TNF)-like ligand 1A (TL1A) and decoy receptor 3 (DcR3) in serum and synovial fluid (SF) of patients with rheumatoid arthritis (RA). To evaluate the effect of recombinant human (rh) TL1A on interleukin (IL)-17 production and IL-17mRNA expression.
METHODS:
The serum and SF levels of TL1A and DcR3, and the production of IL-17 by rhTL1A-treated PBMC were measured by enzyme-linked immunosorbent assay (ELISA). The expression of IL-17 mRNA by rhTL1A-treated PBMC was measured by real-time reverse transcriptase polymerase chain reaction (RT-PCR). We also tested the change of TL1A and DcR3 level following TNF-α blockade therapy.
RESULTS:
Serum TL1A and DcR3 levels were higher in RA patients. This increase was more significant in RF and anti-CCP positive patients. TL1A and DcR3 levels were higher in SF samples than in paired sera. TL1A and DcR3 decreased after anti-TNF treatment. rhTL1A increased the production of IL-17 protein and the expression of IL-17mRNA.
CONCLUSION:
TL1A and DcR3 may be of pathogenic and potentially of therapeutic importance in RA patients.
AuthorsZijuan Xiu, Hui Shen, Ye Tian, Liping Xia, Jing Lu
JournalCytokine (Cytokine) Vol. 72 Issue 2 Pg. 185-9 (Apr 2015) ISSN: 1096-0023 [Electronic] England
PMID25647275 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2015 Elsevier Ltd. All rights reserved.
Chemical References
  • Anti-Inflammatory Agents, Non-Steroidal
  • Interleukin-17
  • Receptors, Tumor Necrosis Factor, Member 6b
  • TNFRSF6B protein, human
  • Tumor Necrosis Factor Ligand Superfamily Member 15
  • Tumor Necrosis Factor-alpha
  • Infliximab
Topics
  • Adult
  • Aged
  • Anti-Inflammatory Agents, Non-Steroidal
  • Arthritis, Rheumatoid (immunology)
  • Enzyme-Linked Immunosorbent Assay
  • Female
  • Humans
  • Infliximab (administration & dosage, therapeutic use)
  • Interleukin-17 (genetics, immunology)
  • Leukocytes, Mononuclear (immunology, metabolism)
  • Male
  • Middle Aged
  • Real-Time Polymerase Chain Reaction
  • Receptors, Tumor Necrosis Factor, Member 6b (blood, metabolism)
  • Synovial Fluid (immunology)
  • Tumor Necrosis Factor Ligand Superfamily Member 15 (blood, metabolism)
  • Tumor Necrosis Factor-alpha (antagonists & inhibitors)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: